Recent Artery Conversations
Please help me understand how laboratory professionals justify establishing every few months with PT/EQA samples when, in reality, bias can change on any day.
Anyone out there performing oligoclonal band testing in CSF? I'm looking at offering a multiple sclerosis screening panel and wondering how challenging the technical performance is.
I’m working on a discussion about the history of PT testing and the development of the initial acceptable limits; if anybody can share pertinent references on the topic or oral history points, please share.
With respect to the current CLIA acceptable limits (for 2024) does anybody know if the minutes of those FDA discussions are available to review the logic of the "deciders" thanks